Contact this trialFirst, we need to learn more about you.
Shorter HER2-targeted Therapy for Breast Cancer
Recruiting3 awardsPhase 4
Ottawa, Ontario
This trial is testing whether 6 months of HER2 targeted therapy is just as effective as the current standard of 1 year for patients with early-stage, HER2 positive breast cancer who achieve a pathological complete response with upfront systemic chemotherapy and HER2 targeted therapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.